Application of Decentralized Clinical Trials in the Research and Development of Drugs for Rare Diseases

Clinical trials of drugs for rare diseases face special challenges such as a limited number of patients, difficult recruitment, long trial period, and frequent video interviews during the trial. Therefore, in the clinical operation of rare diseases, a decentralized clinical trials (DCT) model based...

Full description

Bibliographic Details

Main Authors:	CUI Huanhuan, TANG Ling, CUI Can, YAO Zhuxing, YANG Zhimin, WANG Haixue
Format:	Artigo
Language:	Chinês
Published:	Editorial Office of Journal of Rare Diseases 2024-04-01
Series:	罕见病研究
Subjects:	rare diseases decentralized clinical trials drugs research and development
Online Access:	https://jrd.chard.org.cn/article/doi/10.12376/j.issn.2097-0501.2024.02.004
Tags:	Add Tag No Tags, Be the first to tag this record!